The enhanced population of CD8+ cytotoxic T cells by KHK-6 could represent the functional shift toward a more active and responsive immune state to improve antitumor immunity and therapeutic outcomes in the context of cancer, and this function shift was verified with the results showing the tumor-killing activity of KHK-6. This evidence concerns the gene CD8A and cancer.